Z

Zevra Therapeutics Inc
NASDAQ:ZVRA

Watchlist Manager
Zevra Therapeutics Inc
NASDAQ:ZVRA
Watchlist
Price: 9.03 USD 4.27% Market Closed
Market Cap: 475.2m USD
Have any thoughts about
Zevra Therapeutics Inc?
Write Note

Zevra Therapeutics Inc
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zevra Therapeutics Inc
Net Change in Cash Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Z
Zevra Therapeutics Inc
NASDAQ:ZVRA
Net Change in Cash
-$26.9m
CAGR 3-Years
N/A
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Net Change in Cash
$252m
CAGR 3-Years
N/A
CAGR 5-Years
5%
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Net Change in Cash
$325m
CAGR 3-Years
N/A
CAGR 5-Years
-58%
CAGR 10-Years
-20%
Pfizer Inc
NYSE:PFE
Net Change in Cash
-$1.6B
CAGR 3-Years
N/A
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Net Change in Cash
$6B
CAGR 3-Years
31%
CAGR 5-Years
169%
CAGR 10-Years
N/A
Eli Lilly and Co
NYSE:LLY
Net Change in Cash
$988.2m
CAGR 3-Years
72%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Zevra Therapeutics Inc's Net Change in Cash?
Net Change in Cash
-26.9m USD

Based on the financial report for Jun 30, 2024, Zevra Therapeutics Inc's Net Change in Cash amounts to -26.9m USD.

What is Zevra Therapeutics Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 5Y
-22%

Over the last year, the Net Change in Cash growth was -154%.

Back to Top